Cargando…

The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro

PURPOSE: Per- and poly-fluoroalkyl-substances (PFASs) are synthetic compounds that raised concern due to their potential adverse effects on human health. Long-chain PFAS were banned by government rules in many states, and thus, new emerging PFAS were recently introduced as substitutes. Among these,...

Descripción completa

Detalles Bibliográficos
Autores principales: Coperchini, F., Croce, L., Pignatti, P., Ricci, G., Gangemi, D., Magri, F., Imbriani, M., Rotondi, M., Chiovato, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285310/
https://www.ncbi.nlm.nih.gov/pubmed/33315184
http://dx.doi.org/10.1007/s40618-020-01466-4
_version_ 1783723535283257344
author Coperchini, F.
Croce, L.
Pignatti, P.
Ricci, G.
Gangemi, D.
Magri, F.
Imbriani, M.
Rotondi, M.
Chiovato, L.
author_facet Coperchini, F.
Croce, L.
Pignatti, P.
Ricci, G.
Gangemi, D.
Magri, F.
Imbriani, M.
Rotondi, M.
Chiovato, L.
author_sort Coperchini, F.
collection PubMed
description PURPOSE: Per- and poly-fluoroalkyl-substances (PFASs) are synthetic compounds that raised concern due to their potential adverse effects on human health. Long-chain PFAS were banned by government rules in many states, and thus, new emerging PFAS were recently introduced as substitutes. Among these, Perfluoro{acetic acid, 2-[(5-methoxy-1,3-dioxolan-4-yl)oxy]}, ammonium salt (C6O4) was recently introduced to produce a range of food contact articles and literature data about this compound are scanty. The aim of this study was to evaluate the in vitro effects of exposure to C6O4, compared with PFOA and PFOS on thyroid cells. METHODS: FRTL5 rat-thyroid cell lines and normal human thyroid cells (NHT) were incubated with increasing concentrations of C6O4 for 24, 48, 72, and 144 h to assess cell viability by WST-1. Cell viability was confirmed by AnnexinV/PI staining. Long-chain PFAS (PFOA and PFOS) were used at same concentrations as positive controls. The proliferation of cells exposed to C6O4, PFOA, and PFOS was measured by staining with crystal violet and evaluation of optical density after incubation with SDS. Changes in ROS production by FRTL5 and NHT after exposure to C6O4 at short (10, 20, and 30 min) and long-time points (24 h) were evaluated by cytofluorimetry. RESULTS: C6O4 exposure did not modify FRTL5 and NHT cell viability at any concentration and/or time points with no induction of necrosis/apoptosis. At difference, PFOS exposure reduced cell viability of FRTL5 while and NHT, while PFOA only in FRTL5. FRTL5 and NHT cell proliferation was reduced by incubation with by PFOA and PFOS, but not with C6O4. ROS production by NHT and FRTL5 cells was not modified after C6O4 exposure, at any time/concentration tested. CONCLUSIONS: The present in vitro study constitutes the first evaluation of the potential adverse effects of the new emerging PFAS C6O4 in cultured rat and human thyroid cells, suggesting its safety for thyroid cells in vitro.
format Online
Article
Text
id pubmed-8285310
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-82853102021-07-20 The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro Coperchini, F. Croce, L. Pignatti, P. Ricci, G. Gangemi, D. Magri, F. Imbriani, M. Rotondi, M. Chiovato, L. J Endocrinol Invest Original Article PURPOSE: Per- and poly-fluoroalkyl-substances (PFASs) are synthetic compounds that raised concern due to their potential adverse effects on human health. Long-chain PFAS were banned by government rules in many states, and thus, new emerging PFAS were recently introduced as substitutes. Among these, Perfluoro{acetic acid, 2-[(5-methoxy-1,3-dioxolan-4-yl)oxy]}, ammonium salt (C6O4) was recently introduced to produce a range of food contact articles and literature data about this compound are scanty. The aim of this study was to evaluate the in vitro effects of exposure to C6O4, compared with PFOA and PFOS on thyroid cells. METHODS: FRTL5 rat-thyroid cell lines and normal human thyroid cells (NHT) were incubated with increasing concentrations of C6O4 for 24, 48, 72, and 144 h to assess cell viability by WST-1. Cell viability was confirmed by AnnexinV/PI staining. Long-chain PFAS (PFOA and PFOS) were used at same concentrations as positive controls. The proliferation of cells exposed to C6O4, PFOA, and PFOS was measured by staining with crystal violet and evaluation of optical density after incubation with SDS. Changes in ROS production by FRTL5 and NHT after exposure to C6O4 at short (10, 20, and 30 min) and long-time points (24 h) were evaluated by cytofluorimetry. RESULTS: C6O4 exposure did not modify FRTL5 and NHT cell viability at any concentration and/or time points with no induction of necrosis/apoptosis. At difference, PFOS exposure reduced cell viability of FRTL5 while and NHT, while PFOA only in FRTL5. FRTL5 and NHT cell proliferation was reduced by incubation with by PFOA and PFOS, but not with C6O4. ROS production by NHT and FRTL5 cells was not modified after C6O4 exposure, at any time/concentration tested. CONCLUSIONS: The present in vitro study constitutes the first evaluation of the potential adverse effects of the new emerging PFAS C6O4 in cultured rat and human thyroid cells, suggesting its safety for thyroid cells in vitro. Springer International Publishing 2020-12-14 2021 /pmc/articles/PMC8285310/ /pubmed/33315184 http://dx.doi.org/10.1007/s40618-020-01466-4 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
Coperchini, F.
Croce, L.
Pignatti, P.
Ricci, G.
Gangemi, D.
Magri, F.
Imbriani, M.
Rotondi, M.
Chiovato, L.
The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro
title The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro
title_full The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro
title_fullStr The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro
title_full_unstemmed The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro
title_short The new generation PFAS C6O4 does not produce adverse effects on thyroid cells in vitro
title_sort new generation pfas c6o4 does not produce adverse effects on thyroid cells in vitro
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285310/
https://www.ncbi.nlm.nih.gov/pubmed/33315184
http://dx.doi.org/10.1007/s40618-020-01466-4
work_keys_str_mv AT coperchinif thenewgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT crocel thenewgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT pignattip thenewgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT riccig thenewgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT gangemid thenewgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT magrif thenewgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT imbrianim thenewgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT rotondim thenewgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT chiovatol thenewgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT coperchinif newgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT crocel newgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT pignattip newgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT riccig newgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT gangemid newgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT magrif newgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT imbrianim newgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT rotondim newgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro
AT chiovatol newgenerationpfasc6o4doesnotproduceadverseeffectsonthyroidcellsinvitro